This cluster groups 2 independently calculated changes: Cash & equivalents increased 143.2%; Operating cash flow increased 7.9%.
2 evidence-backed components· Pharmaceutical Preparations
RESEARCH SNAPSHOTAN2 Therapeutics, Inc.'s latest supported as-filed period reports net income of -$8.2M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 143.2%; Operating cash flow increased 7.9%.
2 evidence-backed componentsShares outstanding changed +38.1% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ANTX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-389545SEC ↗4Sep 8, 2026Period Sep 3, 20260001193125-26-385511SEC ↗4Sep 4, 2026Period Sep 1, 20260001193125-26-383697SEC ↗4Sep 2, 2026Period Sep 1, 20260001193125-26-380595SEC ↗4Aug 19, 2026Period Aug 17, 20260001193125-26-357225SEC ↗4Aug 14, 2026Period Aug 14, 20260001193125-26-351801SEC ↗10-QAug 11, 2026Period Jun 30, 20260001193125-26-344569SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 9, 2026Filed Sep 11, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 585 | $6 | $3,524 | Form 4 ↗ |
| Sep 9, 2026Filed Sep 11, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 523 | $6 | $3,151 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 8, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 4,725 | $6 | $28,436 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 8, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 5,294 | $6 | $31,861 | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating income changed -23.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +143.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +88.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -51.4% from the comparable as-filed period.
Operating cash flow changed +7.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +18.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-344549| Readnour Robin ShaneDirector |
| Open Market SaleIndirect |
| 3,223 |
| $6 |
| $19,563 |
| Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 2,877 | $6 | $17,463 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 4, 2026 | Williams Sarah JoannePrincipal Accounting Officer | Open Market SaleDirect | 272 | $6 | $1,504 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 2, 2026 | FitzPatrick Margaret MDirector | Open Market PurchaseDirect | 2,098 | $6 | $11,602 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 19, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 16,696 | $6 | $100,313 | Form 4 ↗ |
| Aug 17, 2026Filed Aug 19, 2026 | Readnour Robin ShaneDirector | Open Market SaleIndirect | 18,706 | $6 | $112,389 | Form 4 ↗ |